TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23972529

Group type: EXPERIMENTAL
Intervention: 10 mg hydrocortisone 30 minutes before a memory encoding task
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: 10 mg hydrocortisone 210 minutes before a memory encoding task
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo at both times
Number of subjects: 64
Study: 21795500

Group type: EXPERIMENTAL
Intervention: Goserelin and ibandronate plus screening
Number of subjects: 31

Group type: COMPARATOR
Intervention: Screening only
Number of subjects: 31
Study: 19318632

Group type: EXPERIMENTAL
Intervention: TPF (docetaxel, cisplatin, 5-fluorouracil)
Number of subjects: 213

Group type: COMPARATOR
Intervention: PF (cisplatin, 5-fluorouracil)
Number of subjects: 213
Study: 16525578

Group type: EXPERIMENTAL
Intervention: Warm-up exercise (WUE)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: High-intensity exercise (HIE)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Light-intensity exercise (LIE)
Number of subjects: 23
Study: 12598488

Group type: EXPERIMENTAL
Intervention: Apneic facial immersion in 6.0 ± 1.2 degrees C water under -20 mmHg LBNP
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Apneic facial immersion in 6.0 ± 1.2 degrees C water during +40 mmHg LBPP
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Apneic facial immersion in 6.0 ± 1.2 degrees C water during postexercise hypotension (PEH)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Apneic facial immersion in 6.0 ± 1.2 degrees C water during normal resting (control)
Number of subjects: 6
Study: 10766888

Group type: EXPERIMENTAL
Intervention: Entacapone (200 mg) with standard Sinemet
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Entacapone (200 mg) with Sinemet CR
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo with standard Sinemet
Number of subjects: 14
Study: 9291769

Group type: EXPERIMENTAL
Intervention: Laryngeal mask airway
Number of subjects: 26

Group type: COMPARATOR
Intervention: Tracheal tube
Number of subjects: 26
Study: 8142334

Group type: EXPERIMENTAL
Intervention: Maternal milk-free diet during late pregnancy and lactation
Number of subjects: 38

Group type: COMPARATOR
Intervention: Unrestricted diet (atopic group)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Unrestricted diet (non-atopic group)
Number of subjects: 38
Study: 3163301

Group type: EXPERIMENTAL
Intervention: Cefotetan (4 gm)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Gentamicin and Metronidazole (5-day cover)
Number of subjects: 152
Study: 29650807

Group type: EXPERIMENTAL
Intervention: HCT care coordination (CC) intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 27919251

Group type: EXPERIMENTAL
Intervention: Sensory awareness training
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Additional motor practice
Number of subjects: 44

Group type: COMPARATOR
Intervention: Usual teaching only (Control)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Grip-lift task (Preload Duration for the non-dominant hand)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 44
Study: 26290103

Group type: EXPERIMENTAL
Intervention: 30 g/120 kcal whey protein
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 70 g/280 kcal whey protein
Number of subjects: 16

Group type: COMPARATOR
Intervention: Flavored water control drink (0 g whey protein)
Number of subjects: 16

Group type: COMPARATOR
Intervention: All three drinks (including control)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Whey protein
Number of subjects: 16
Study: 23287635

Group type: EXPERIMENTAL
Intervention: Progesterone injection plus oral E2 supplementation (Group A)
Number of subjects: 402

Group type: COMPARATOR
Intervention: Progesterone injection alone (Group B)
Number of subjects: 402
Study: 20568427

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with cupping and western medicine (group A)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Acupuncture combined with cupping (group B)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Western medicine (group C)
Number of subjects: 186
Study: 18223390

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 16987363

Group type: EXPERIMENTAL
Intervention: E120 group (120 mg etoricoxib)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: E + P group (120 mg etoricoxib + 1 g paracetamol)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Pla group (placebo)
Number of subjects: 75
Study: 14501603

Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogens (Premarin, 1.25 mg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 11073759

Group type: EXPERIMENTAL
Intervention: Azithromycin 600 mg every day combined with ethambutol
Number of subjects: 246

Group type: COMPARATOR
Intervention: Clarithromycin 500 mg twice a day combined with ethambutol
Number of subjects: 246
Study: 9358617

Group type: EXPERIMENTAL
Intervention: Prothrombin complex concentrates (PCC)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Experimental product series of PCC
Number of subjects: 56
Study: 1286738

Group type: EXPERIMENTAL
Intervention: ViviScal (two tablets once daily for 6 months)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Fish extract (two tablets once daily for 6 months)
Number of subjects: 20
Study: 2844334

Group type: EXPERIMENTAL
Intervention: Intravenous foscarnet
Number of subjects: 30
Study: 28724200

Group type: EXPERIMENTAL
Intervention: Memantine 30 mg twice daily for 7 days
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group (standard TBI management)
Number of subjects: 41
Study: 27849461

Group type: EXPERIMENTAL
Intervention: Ossur Variflex
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Endolite Elite Blade
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Ossur Re‐Flex Rotate
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control (nonamputee)
Number of subjects: 14
Study: 24280041

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training (65%-80% of maximal heart rate, 40-60 min/day, 3-6 days/week for 12 weeks)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (n = 10)
Number of subjects: 30
Study: 23169607

Group type: EXPERIMENTAL
Intervention: ACE-031 (3 mg/kg s.c.)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: ACE-031
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 21122637

Group type: EXPERIMENTAL
Intervention: Extended-release niacin/laropiprant (ERN/LRPT)
Number of subjects: 4747

Group type: COMPARATOR
Intervention: ERN-Niaspan (ERN-NSP)
Number of subjects: 4747

Group type: COMPARATOR
Intervention: Simvastatin or placebo (SIMVA-PBO)
Number of subjects: 4747
Study: 18435331

Group type: EXPERIMENTAL
Intervention: Infusion removal first (Group 1, 30 eyes)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Infusion removal after another cannula (Group 2, 32 eyes)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Infusion removal last (Group 3, 33 eyes)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Hypotony persisted through postoperative day 2 (IOP <= 5 mm Hg)
Number of subjects: 109
Study: 16139962

Group type: COMPARATOR
Intervention: Standard Behavioral Intervention (SB)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Relapse Prevention Intervention (RP)
Number of subjects: 79
Study: 12499519

Group type: EXPERIMENTAL
Intervention: Direct Stenting (DS)
Number of subjects: 271

Group type: COMPARATOR
Intervention: Predilatation Stenting (PS)
Number of subjects: 271
Study: 10806605

Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide (Azmacort HFA 225 mcg Inhalation Aerosol)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Budesonide (Pulmicort Turbuhaler 200 mcg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide and Budesonide
Number of subjects: 18
Study: 9015909

Group type: EXPERIMENTAL
Intervention: Salmon calcitonin, 1 x 100 IU/day intramuscularly for 4 weeks
Number of subjects: 41

Group type: COMPARATOR
Intervention: Physiological saline, 1 ml/day intramuscularly for 4 weeks
Number of subjects: 41
Study: 1321181

Group type: EXPERIMENTAL
Intervention: Vascularized sural nerve grafts
Number of subjects: 49

Group type: COMPARATOR
Intervention: Conventional sural nerve grafts
Number of subjects: 49
Study: 6638669

Group type: EXPERIMENTAL
Intervention: Activated charcoal (4 doses of 30 g each, administered every 2 hours)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Activated charcoal (4 doses of 30 g every 2 hours) in a patient with initial serum theophylline concentration of 31.0 micrograms/ml and signs of toxicity
Number of subjects: 7

Group type: COMPARATOR
Intervention: No activated charcoal (control group)
Number of subjects: 7
Study: 30268806

Group type: EXPERIMENTAL
Intervention: 8-week online mindfulness training intervention (n=28)
Number of subjects: 55

Group type: COMPARATOR
Intervention: 8-week psychoeducational materials (control group, n=27)
Number of subjects: 55
Study: 30143005

Group type: EXPERIMENTAL
Intervention: Tyrosine nitrosylation
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: Tyr-NO2 levels
Number of subjects: 278

Group type: EXPERIMENTAL
Intervention: Tyrosine/Tyr-NO2 ratio
Number of subjects: 278
Study: 27527501

Group type: EXPERIMENTAL
Intervention: Early mobilisation combined with endurance and resistance training
Number of subjects: 115

Group type: COMPARATOR
Intervention: Standard physiotherapy (Control)
Number of subjects: 115
Study: 24530600

Group type: EXPERIMENTAL
Intervention: 50 mg ASP9831
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: 100 mg ASP9831
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study: 23094083

Group type: EXPERIMENTAL
Intervention: Energy bar supplementation (4.1 MJ•day(‐1))
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group with traditional field rations
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 26
Study: 20676027

Group type: EXPERIMENTAL
Intervention: Laparoscopic colectomy
Number of subjects: 24

Group type: COMPARATOR
Intervention: Open colectomy
Number of subjects: 24
Study: 17437506

Group type: EXPERIMENTAL
Intervention: Group 1 (more than 6 bands per session)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Group 2 (up to 6 bands per session)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Overall (both groups)
Number of subjects: 86
Study: 15866088

Group type: EXPERIMENTAL
Intervention: Risedronate (5 mg/day) plus atorvastatin (20 mg/day)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Risedronate (5 mg/day)
Number of subjects: 120
Study: 12410869

Group type: EXPERIMENTAL
Intervention: De‐Lact (low‐osmolality lactose‐free formula)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: O‐Lac (lactose‐free formula)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Alfaré (partially hydrolysed formula)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: De‐Lact (low‐osmolality lactose‐free formula) in malnourished subgroup
Number of subjects: 180
Study: 10340182

Group type: EXPERIMENTAL
Intervention: Cholinesterase inhibitors treatment initiated and monitored by primary care physicians
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cholinesterase inhibitors treatment
Number of subjects: 0
Study: 9118296

Group type: EXPERIMENTAL
Intervention: p55 clonality assay
Number of subjects: 37

Group type: COMPARATOR
Intervention: G6PD assay
Number of subjects: 37
Study: 2192570

Group type: EXPERIMENTAL
Intervention: Continuous propofol infusion with analgesia from bolus doses of papaveretum
Number of subjects: 37

Group type: COMPARATOR
Intervention: Continuous infusion of papaveretum supplemented by bolus doses of midazolam
Number of subjects: 37
Study: 395771

Group type: EXPERIMENTAL
Intervention: Chondroitin sulfate isomers (4.5 g per day for 64 months)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Chondroitin polysulfate (4.5 g per day for 64 months)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Chondroitin 4-sulfate and/or chondroitin 6-sulfate (4.5 g per day for 64 months)
Number of subjects: 48
Study: 30938691

Group type: EXPERIMENTAL
Intervention: Smartphone app (multifaceted Android or iOS app comprising a personalized profile and quit plan, text and in-app motivational messages, and a challenge feature)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Usual cessation support services (control group)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Smartphone app
Number of subjects: 49
Study: 28950149

Group type: EXPERIMENTAL
Intervention: FLOSS (floss band applied to both ankles)
Number of subjects: 69

Group type: COMPARATOR
Intervention: CON (without flossing of the ankle joints)
Number of subjects: 69
Study: 25952471

Group type: EXPERIMENTAL
Intervention: Centralized web-based cardiovascular risk service (CVRS) managed by clinical pharmacists, intervention duration of 12 months.
Number of subjects: 12

Group type: COMPARATOR
Intervention: Usual care (control group), duration of 12 months.
Number of subjects: 12
Study: 23968802

Group type: EXPERIMENTAL
Intervention: Modified instructional format designed to reduce cognitive load
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control instructional format
Number of subjects: 24
Study: 21254788

Group type: EXPERIMENTAL
Intervention: Aripiprazole as adjunctive therapy to antidepressants
Number of subjects: 1090

Group type: COMPARATOR
Intervention: Aripiprazole
Number of subjects: 1090
Study: 19450035

Group type: EXPERIMENTAL
Intervention: Resisting tempting sweets
Number of subjects: 101

Group type: COMPARATOR
Intervention: Resisting less tempting vegetables
Number of subjects: 101
Study: 18833207

Group type: EXPERIMENTAL
Intervention: Labial infiltration of the maxillary central incisors
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional injection into incisive papilla (Control)
Number of subjects: 60
Study: 16336912

Group type: EXPERIMENTAL
Intervention: Particulated bone mixed with PRP (test)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Onlay block grafts without additional PRP (control)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Particulated bone grafts with PRP (test)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Particulated bone grafts without PRP (control)
Number of subjects: 19
Study: 11882746

Group type: EXPERIMENTAL
Intervention: nizatidine 75 mg twice daily
Number of subjects: 51

Group type: COMPARATOR
Intervention: placebo tablet twice daily
Number of subjects: 51
Study: 10225502

Group type: EXPERIMENTAL
Intervention: Standard Eye Movement Desensitization and Reprocessing (EMDR) treatment
Number of subjects: 27

Group type: COMPARATOR
Intervention: Similar treatment without the explicit cognitive elements found in EMDR
Number of subjects: 27
Study: 8907208

Group type: EXPERIMENTAL
Intervention: Surgery group (partial ileal bypass)
Number of subjects: 838
Study: 2676530

Group type: EXPERIMENTAL
Intervention: Fentanyl and midazolam
Number of subjects: 50

Group type: COMPARATOR
Intervention: Fentanyl and two-stage infusion of propofol in a subanaesthetic dose
Number of subjects: 50
Study: 1001000

Group type: EXPERIMENTAL
Intervention: Acebutolol (100 mg to 1200 mg/day in divided doses)
Number of subjects: 427
Study: 31697365

Group type: EXPERIMENTAL
Intervention: Tailored geriatric assessment (GA) summary with recommendations for each enrolled patient
Number of subjects: 541

Group type: COMPARATOR
Intervention: Usual care (alerts only for patients meeting criteria for depression or cognitive impairment)
Number of subjects: 541
Study: 30189371

Group type: EXPERIMENTAL
Intervention: Fatigue group (shuttle-run test to maximal exhaustion)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (resting in sitting position for 15 minutes)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Fatigue group
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 29173690

Group type: EXPERIMENTAL
Intervention: Omega-3 group (daily intake of 1080mg EPA + 200mg DHA for 12 weeks)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Omega-3 group
Number of subjects: 49
Study: 26367143

Group type: EXPERIMENTAL
Intervention: Manipulation under anaesthesia (MUA)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Manipulation under anaesthesia (MUA) with additional subacromial injection of triamcinolone and bupivacain
Number of subjects: 30
Study: 23201448

Group type: EXPERIMENTAL
Intervention: FraxiPure™ (1000 mg daily for 90 days)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: FraxiPure™
Number of subjects: 100
Study: 21615691

Group type: EXPERIMENTAL
Intervention: Paracetamol 1 g and Ketorolac 20 mg combination
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Ketorolac 20 mg
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Paracetamol 1 g
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Cold pressor test
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 18292916

Group type: EXPERIMENTAL
Intervention: Electroacupuncture plus exercise
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Interferential electrotherapy plus exercise
Number of subjects: 70

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 70
Study: 16804739

Group type: EXPERIMENTAL
Intervention: Personalized letter plus offer of a free bone mineral density (BMD) test (n=80)
Number of subjects: 254

Group type: COMPARATOR
Intervention: Personalized letter only (n=79)
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: Both groups (personalized letter and personalized letter plus BMD offer)
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: Participants who contacted their primary care physician
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: Participants tested for BMD
Number of subjects: 254
Study: 12637702

Group type: EXPERIMENTAL
Intervention: Aspirin (100 to 300 mg/d)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Clopidogrel (75 mg/d)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Aspirin and Clopidogrel (combined therapy)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 31
Study: 10818061

Group type: EXPERIMENTAL
Intervention: Nifedipine once daily
Number of subjects: 5669

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide/amiloride
Number of subjects: 5669

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5669

Group type: EXPERIMENTAL
Intervention: Second-line drugs (Atenolol or Enalapril)
Number of subjects: 5669

Group type: EXPERIMENTAL
Intervention: Isolated systolic hypertension treatment
Number of subjects: 5669
Study: 8641121

Group type: EXPERIMENTAL
Intervention: Amoxicillin plus clavulanic acid
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 1522663

Group type: EXPERIMENTAL
Intervention: Single prophylactic injection of gentamicin
Number of subjects: 100

Group type: COMPARATOR
Intervention: Five days course of gentamicin
Number of subjects: 100
Study: 6404121

Group type: EXPERIMENTAL
Intervention: Disoprofol with fentanyl
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Disoprofol with alfentanil
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Disoprofol with midazolam
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Disoprofol without premedication
Number of subjects: 60
Study: 30391169

Group type: EXPERIMENTAL
Intervention: Rupatadine 10 mg
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Rupatadine 20 mg
Number of subjects: 900

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 900
Study: 29846435

Group type: EXPERIMENTAL
Intervention: Aerobic interval training (AIT) program, conducted three times a week for 16 weeks at an intensity equivalent to 70-110% of ventilatory anaerobic threshold (VAT).
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Aerobic interval training (AIT) program, conducted three times a week for 16 weeks.
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned).
Number of subjects: 66
Study: 27809925

Group type: EXPERIMENTAL
Intervention: Guided self-help intervention delivered over the telephone for common mental health disorders, 10 sessions
Number of subjects: 18

Group type: COMPARATOR
Intervention: Waiting list control group (12-week waiting period)
Number of subjects: 18
Study: 25312396

Group type: EXPERIMENTAL
Intervention: Nintedanib (BIBF 1120) at a dose of 200mg twice daily
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Nintedanib (BIBF 1120)
Number of subjects: 32
Study: 22924178

Group type: EXPERIMENTAL
Intervention: Free air carbon dioxide enrichment (550 ppm)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Drought (precipitation exclusion)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Temperate climate (THI 57‐63)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mild heat (THI 68‐71)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Severe heat (THI 75‐80)
Number of subjects: 0
Study: 20970572

Group type: EXPERIMENTAL
Intervention: 1 μg/d paricalcitol (n=25)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (n=17)
Number of subjects: 42
Study: 18039918

Group type: EXPERIMENTAL
Intervention: Resiquimod 0.01% gel applied two times per week for 3 weeks
Number of subjects: 82

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 82
Study: 16135920

Group type: EXPERIMENTAL
Intervention: Laparoscopic herniorrhaphy by inexperienced surgeons aged 45 years or older
Number of subjects: 1629

Group type: EXPERIMENTAL
Intervention: Open herniorrhaphy
Number of subjects: 1629
Study: 12021625

Group type: EXPERIMENTAL
Intervention: Azathioprine or 6-mercaptopurine
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Concomitant methotrexate
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Low TPMT activity in adult patients with inflammatory bowel disease
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: TPMT activity
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Concentrations of methylthioinosine monophosphate or thioguanine nucleotides
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Thiopurine metabolism
Number of subjects: 122
Study: 10071518

Group type: EXPERIMENTAL
Intervention: cetirizine 10 mg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: loratadine 10 mg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: diphenhydramine 50 mg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: chlorpheniramine 8 mg
Number of subjects: 15

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: All H1-receptor antagonists
Number of subjects: 15